1. Public Health England. Human Papillomavirus (HPV) Vaccine Coverage in England, 2008/09 to 2013/14: A review of the full six years of the three-dose schedule. 2015. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/412264/HPV_Vaccine_Coverage_in_England_200809_to_201314.pdf (accessed Mar 2016).
2. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial;Harper;Lancet,2006
3. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial;Villa;Lancet Oncol,2005
4. Detection of specific HPV subtypes responsible for the pathogenesis of condylomata acuminata;Hawkins;Virol J,2013
5. Public Health England. Continuing trend of declining genital warts diagnoses in young women in England associated with HPV 16/18 vaccination: update to end-2014, in Health Protection Report. 2015. https://www.gov.uk/government/publications/health-protection-report-volume-9-2015/hpr-volume-9-issue-22-news-26-june (accessed Mar 2015).